Doxycycline
Doxycycline is a pharmaceutical drug with 189 clinical trials. Currently 21 active trials ongoing. Historical success rate of 88.0%.
Success Metrics
Based on 110 completed trials
Phase Distribution
Phase Distribution
17
Early Stage
48
Mid Stage
81
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.5%
110 of 135 finished
18.5%
25 ended early
21
trials recruiting
189
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Treatments on Atopic Dermatitis
Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment
Clinical Trials (189)
Effects of Treatments on Atopic Dermatitis
Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens
A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Phase II Trial of First-line Doxycycline for Ocular Adnexal Marginal Zone Lymphoma Treatment
Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
Weekly Doxycycline DOT for STI Prevention Among Cisgender Women Taking HIV PrEP in Kisumu, Kenya
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro
Doxycycline Use in Post-Operative Seromas
A Study of Doxycycline to Treat Chlamydial Infection
The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea
Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
Treatment Responses of Early Syphilis to Ceftriaxone Plus Doxycycline
Lipidome and Microbiome Profile of Acne
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 189